Preferred Label : piperidines;

MeSH definition : A family of hexahydropyridines.;

Wikipedia link : https://en.wikipedia.org/wiki/Piperidines;

Is substance : O;

Details


Main resources

You can consult :

A family of hexahydropyridines.

https://ansm.sante.fr/tableau-marr/vandetanib
2024
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
RET Gene Mutation
guidelines for drug use
piperidines
quinazolines
piperidines
quinazolines

---
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/juin-2021.html#a5.4
2021
false
false
false
Canada
French
English
drug approval
canada
drug information
tepotinib
administration, oral
adult
carcinoma, non-small-cell lung
c-Met Inhibitor
protein kinase inhibitors
tepotinib
neoplasm metastasis
piperidines
pyridazines
pyrimidines

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64454186
2021
false
false
false
France
French
bilastine
summary of product characteristics
package leaflet
bilastine
benzimidazoles
piperidines

---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75315a-fra.php
2021
false
false
false
Canada
French
English
drug information
tofacitinib
neoplasms
heart diseases
arthritis, rheumatoid
arthritis, psoriatic
administration, oral
colitis, ulcerative
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/jcms/p_3243403/fr/zejula
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Niraparib Tosylate Monohydrate
niraparib
Poly(ADP-ribose) Polymerase Inhibitors
niraparib
administration, oral
adult
Carcinoma, Ovarian Epithelial
fallopian tube neoplasms
peritoneal neoplasms
Fallopian Tube Carcinoma
Peritoneal carcinoma
evaluation of the transparency committee
indazoles
piperidines

---
https://ansm.sante.fr/tableau-atu-rtu/ozawade-4-5-mg-18-mg-comprimes-pellicules
2021
false
false
false
France
French
guidelines for drug use
administration, oral
pitolisant
pitolisant
Excessive Daytime Sleepiness
sleep apnea, obstructive
adult
disorders of excessive somnolence
piperidines
piperidines

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-les-resultats-preliminaires-dun-essai-clinique-indiquent-une-augmentation-du-risque-devenements-cardiovasculaires-et-de-tumeurs-malignes-en-comparaison-aux-anti-tnf-alpha
2021
false
false
false
France
French
clinical trials as topic
tofacitinib
neoplasms
cardiovascular diseases
risk
Janus Kinase Inhibitors
arthritis, rheumatoid
tofacitinib
pharmacovigilance note
pyrimidines
pyrroles
piperidines

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-augmentation-du-risque-devenements-cardiovasculaires-indesirables-majeurs-et-de-tumeurs-malignes-avec-lutilisation-de-tofacitinib-en-comparaison-aux-antitnf-alpha
2021
false
false
false
France
French
pharmacovigilance note
tofacitinib
cardiovascular diseases
risk
neoplasms
tofacitinib
tofacitinib
arthritis, rheumatoid
major adverse cardiovascular events
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://ansm.sante.fr/uploads/2020/10/30/20201030-dhpc-xeljanz.pdf
2020
false
false
false
France
French
tofacitinib
guidelines for drug use
administration, oral
protein kinase inhibitors
protein kinase inhibitors
risk factors
thrombosis
embolism and thrombosis
Drug-Related side effects and adverse reactions
tofacitinib
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
venous thromboembolism
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.ansm.sante.fr/actualites/xeljanz-tofacitinib-lansm-demande-aux-professionnels-de-sante-et-aux-patients-de-bien-respecter-la-dose-autorisee-dans-le-traitement-de-la-polyarthrite-rhumatoide
2019
false
false
false
France
French
administration, oral
pharmacovigilance note
tofacitinib citrate
arthritis, rheumatoid
pulmonary embolism
tofacitinib citrate
tofacitinib
risk factors
tofacitinib
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_18_Spondyloarthrites_MAJ_220719.pdf
2019
false
false
false
France
adult
tofacitinib
tofacitinib
administration, oral
baricitinib
baricitinib
spondylitis, ankylosing
arthritis, psoriatic
guideline
Janus Kinase Inhibitors
spondylarthropathies
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_09_Digestif_Hepatiq_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
hepatic insufficiency
hepatitis B
hepatitis C
tofacitinib
baricitinib
Alanine aminotransferase outside reference range (finding)
transaminases
intestinal perforation
arthritis, rheumatoid
guideline
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_08_Aff%20Hemato_MAJ_200819.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
baricitinib
tofacitinib
Janus Kinase Inhibitors
risk factors
blood cell count
continuity of patient care
neutropenia
lymphopenia
anemia
algorithms
guideline
hematologic diseases
lymphoma
arthritis, rheumatoid
azetidines
sulfonamides
pyrimidines
pyrroles
piperidines

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_07_Cancer_MAJ_220719.pdf
2019
false
false
false
France
neoplasms
risk
Janus Kinase Inhibitors
Janus Kinase Inhibitors
tofacitinib
baricitinib
guideline
arthritis, rheumatoid
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKI-octobre2019/JAK_06_%20Cardio_MAJ_220719.pdf
2019
false
false
false
France
Janus Kinase Inhibitors
cardiovascular agents
anticoagulants
tofacitinib
baricitinib
cholesterol
Janus Kinase Inhibitors
risk
risk factors
drug interactions
guideline
arthritis, rheumatoid
cardiovascular diseases
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71766a-fra.php
2019
false
false
false
Canada
French
English
tofacitinib
thrombosis
risk
pharmacovigilance note
tofacitinib
pulmonary embolism
deep vein thrombosis
guidelines for drug use
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
risk factors
patients guideline
venous thrombosis
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/jcms/c_2912419/fr/xeljanz
2019
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
tofacitinib
tofacitinib citrate
colitis, ulcerative
protein kinase inhibitors
janus kinases
adult
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
tofacitinib
pyrimidines
pyrroles
piperidines

---
https://www.ansm.sante.fr/actualites/restriction-dutilisation-du-xeljanz-tofacitinib
2019
false
false
false
France
French
guidelines for drug use
tofacitinib
protein kinase inhibitors
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
administration, oral
tofacitinib
pulmonary embolism
tofacitinib
protein kinase inhibitors
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://ansm.sante.fr/informations-de-securite/xeljanz-tofacitinib-ne-plus-prescrire-10-mg-deux-fois-par-jour-chez-les-patients-ayant-un-risque-eleve-dembolie-pulmonaire
2019
false
false
false
France
French
administration, oral
tofacitinib
pharmacovigilance note
guidelines for drug use
pulmonary embolism
risk
arthritis, rheumatoid
tofacitinib
risk assessment
risk factors
tofacitinib
colitis, ulcerative
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/portail/jcms/c_2912132/fr/caprelsa
2019
false
true
false
false
France
administration, oral
treatment outcome
vandetanib
insurance, health, reimbursement
protein kinase inhibitors
adult
adolescent
child
thyroid cancer, medullary
neoplasm metastasis
caprelsa
piperidines
quinazolines
evaluation of the transparency committee
vandetanib
piperidines
quinazolines
carcinoma, neuroendocrine
thyroid neoplasms

---
Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69336a-fra.php
2019
false
false
false
Canada
French
English
pharmacovigilance note
arthritis, rheumatoid
tofacitinib
administration, oral
tofacitinib
protein kinase inhibitors
tofacitinib
pulmonary embolism
protein kinase inhibitors
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
https://www.has-sante.fr/portail/jcms/c_2857802/fr/alecensa
https://www.has-sante.fr/portail/jcms/c_2857802/fr/alecensa-alectinib-inhibiteur-de-tyrosine-kinase
2018
false
false
false
France
French
treatment outcome
administration, oral
carcinoma, non-small-cell lung
alectinib
protein kinase inhibitors
adult
aged
antineoplastic agents
evaluation of the transparency committee
survival analysis
ALK gene rearrangement positive
guidelines for drug use
Tyrosine Kinase Inhibitors
alectinib
alectinib
carbazoles
piperidines
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
https://ansm.sante.fr/informations-de-securite/zelboraf-cotellic-v-rappel-du-risque-datteintes-opthalmiques-et-de-leur-prise-en-charge
2018
false
false
false
France
French
pharmacovigilance note
retinal diseases
vision disorders
cobimetinib
continuity of patient care
mass screening
risk
guidelines for drug use
pharmacovigilance
uveitis
cobimetinib
indoles
sulfonamides
azetidines
piperidines
Vemurafenib

---
https://www.has-sante.fr/portail/jcms/c_2867845/fr/zejula
https://www.has-sante.fr/portail/jcms/c_2867845/fr/zejula-niraparib-inhibiteur-de-parp-poly-adp-ribose-polymerase
2018
false
false
false
France
French
treatment outcome
orphan drug production
adult
ovarian neoplasms
neoplasm recurrence, local
Maintenance Therapy
administration, oral
Poly(ADP-ribose) Polymerase Inhibitors
drug interactions
Poly (ADP-Ribose) Polymerase-1
PARP2 protein, human
fallopian tube neoplasms
peritoneal neoplasms
Advanced Malignant Neoplasm
niraparib
evaluation of the transparency committee
guidelines for drug use
niraparib
indazoles
piperidines
neoplasms, glandular and epithelial
Poly(ADP-ribose) polymerases
Carcinoma, Ovarian Epithelial

---
https://www.has-sante.fr/portail/jcms/c_2880169/fr/levofree
2018
false
false
false
France
levocabastine
insurance, health, reimbursement
treatment outcome
conjunctivitis, allergic
levocabastine
evaluation of the transparency committee
piperidines

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-patients-JAKi
2018
false
false
false
France
continuity of patient care
pregnancy
vaccination
travel
virus diseases
bacterial infections
cardiovascular diseases
neoplasms
lymphoma
digestive system diseases
hematologic diseases
dental care
surgical procedures, operative
tofacitinib
baricitinib
drug therapy, combination
arthritis, rheumatoid
Contraindications, Drug
drug interactions
Evidence-Based medicine
baricitinib
tofacitinib
guidelines for drug use
case management
Janus Kinase Inhibitors
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.has-sante.fr/portail/jcms/c_2894923/en/xeljanz
2018
false
false
false
France
administration, oral
arthritis, psoriatic
adult
treatment outcome
insurance, health, reimbursement
protein kinase inhibitors
evaluation of the transparency committee
tofacitinib
pyrimidines
pyrroles
piperidines

---
https://pharmacomedicale.org/medicaments/par-specialites/item/glinides
2018
false
true
false
France
hypoglycemic agents
repaglinide
diabetes mellitus, type 2
drug information
carbamates
piperidines

---
https://www.has-sante.fr/portail/jcms/c_2851234/fr/donepezil-biogaran
2018
false
false
false
false
France
French
evaluation of the transparency committee
indans
piperidines
Donepezil

---
http://www.prescrire.org/Fr/3/31/55116/0/NewsDetails.aspx
2018
false
false
false
false
France
French
alzheimer disease
treatment outcome
donepezil hydrochloride
donepezil
cholinesterase inhibitors
cholinesterase inhibitors
insurance, health, reimbursement
alzheimer disease
memantine
memantine
memantine hydrochloride
receptors, n-methyl-d-aspartate
excitatory amino acid antagonists
excitatory amino acid antagonists
administration, oral
administration, cutaneous
Rivastigmine
rivastigmine
galantamine
Galanthamine Hydrobromide
quality of life
france
journal article
galantamine
indans
piperidines
Donepezil

---
https://www.has-sante.fr/portail/jcms/c_2851228/fr/aricept
2018
false
false
false
false
France
French
evaluation of the transparency committee
Aricept
indans
piperidines
Donepezil

---
https://ansm.sante.fr/tableau-atu-rtu/niraparib-tesaro-100-nbsp-mg-gelule
2018
false
false
false
France
French
drug information
niraparib
capsules
niraparib
indazoles
piperidines

---
https://www.ema.europa.eu/medicines/human/EPAR/Alecensa
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
alectinib
administration, oral
carcinoma, non-small-cell lung
alectinib
alectinib
protein kinase inhibitors
protein kinase inhibitors
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
fertility
antineoplastic agents
antineoplastic agents
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
alectinib
alectinib
carbazoles
piperidines
carbazoles
piperidines
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
https://www.ema.europa.eu/medicines/human/EPAR/Xeljanz
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tofacitinib
drug approval
europe
treatment outcome
tofacitinib
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
administration, oral
continuity of patient care
drug monitoring
janus kinases
pregnancy
breast feeding
drug interactions
protein kinase inhibitors
protein kinase inhibitors
product surveillance, postmarketing
aged
drug evaluation, preclinical
Product containing tofacitinib (medicinal product)
Tofacitinib 5mg tablet (product)
Tyrosine Kinase Inhibitors
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
Summary Basis of Decision (SBD) for Bepreve
Bepotastine besilate, 1.5% w/v, solution, ophthalmic
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00324
2017
false
false
false
Canada
French
English
drug information
administration, ophthalmic
bepotastine besilate
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug)
piperidines
pyridines

---
https://www.has-sante.fr/portail/jcms/c_2788638/fr/kestin-kestinlyo
2017
false
false
false
France
French
evaluation of the transparency committee
ebastine
butyrophenones
piperidines

---
https://www.ema.europa.eu/medicines/human/EPAR/Zejula
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
niraparib
drug approval
europe
treatment outcome
product surveillance, postmarketing
orphan drug production
adult
ovarian neoplasms
neoplasm recurrence, local
Maintenance Therapy
administration, oral
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical
Poly (ADP-Ribose) Polymerase-1
PARP2 protein, human
fallopian tube neoplasms
peritoneal neoplasms
Advanced Malignant Neoplasm
Progression-Free survival
niraparib
niraparib
indazoles
piperidines
disease-free survival
indazoles
piperidines
Poly(ADP-ribose) polymerases
neoplasms, glandular and epithelial
Carcinoma, Ovarian Epithelial

---
https://www.has-sante.fr/portail/jcms/c_2798163/fr/xeljanz-tofacitinib-anti-jak-1-et-3
https://www.has-sante.fr/portail/jcms/c_2798163/fr/xeljanz
2017
false
false
false
France
French
tofacitinib
treatment outcome
tofacitinib
adult
arthritis, rheumatoid
drug therapy, combination
methotrexate
administration, oral
continuity of patient care
protein kinase inhibitors
protein kinase inhibitors
aged
Product containing tofacitinib (medicinal product)
Tofacitinib 5mg tablet (product)
guidelines for drug use
evaluation of the transparency committee
janus kinase 1
janus kinase 3
insurance, health, reimbursement
risk
Tyrosine Kinase Inhibitors
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines

---
http://www.has-sante.fr/portail/jcms/c_2620147/fr/cotellic
http://www.has-sante.fr/portail/jcms/c_2620147/fr/cotellic-cobimetinib-anti-mek-inhibiteur-de-proteine-kinase
2016
false
false
false
France
French
cobimetinib
cobimetinib
vemurafenib
melanoma
neoplasm metastasis
administration, oral
MAP kinase kinase 1
antineoplastic agents
antineoplastic agents
adult
continuity of patient care
treatment outcome
antineoplastic combined chemotherapy protocols
melanoma
BRAF gene mutation
evaluation of the transparency committee
Metastatic Melanoma
Unresectable Malignant Neoplasm
guidelines for drug use
cobimetinib
Tyrosine Kinase Inhibitors
cobimetinib
cobimetinib
azetidines
piperidines
azetidines
piperidines
indoles
sulfonamides
Vemurafenib

---
https://www.ema.europa.eu/medicines/human/EPAR/Wakix
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
piperidines
drug approval
europe
treatment outcome
adult
orphan drug production
narcolepsy
administration, oral
pitolisant
receptors, histamine h3
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pitolisant
piperidines
pitolisant

---
http://www.has-sante.fr/portail/jcms/c_2630025/fr/repaglinide-arrow-lab
2016
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
repaglinide
carbamates
piperidines

---
http://www.has-sante.fr/portail/jcms/c_2656361/fr/wakix
2016
false
false
false
France
French
piperidines
treatment outcome
adult
orphan drug production
narcolepsy
administration, oral
pitolisant
receptors, histamine h3
insurance, health, reimbursement
evaluation of the transparency committee
Narcolepsy-Cataplexy syndrome
Narcolepsy without cataplexy (disorder)
pitolisant
piperidines
pitolisant

---
http://www.has-sante.fr/portail/jcms/c_2656361/fr/wakix-pitolisant-antagoniste/agoniste-inverse-des-recepteurs-h3-a-l-histamine
2016
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
administration, oral
treatment outcome
insurance, health, reimbursement
pitolisant
histamine h3 antagonists
histamine h3 antagonists
narcolepsy
orphan drug production
pitolisant
pitolisant
piperidines
piperidines

---
Summary Basis of Decision (SBD) for Alecensaro
Alectinib (as alectinib hydrochloride), 150 mg, capsule, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00332
2016
false
false
false
Canada
French
English
administration, oral
treatment outcome
alectinib
alectinib
drug approval
canada
risk assessment
protein kinase inhibitors
protein kinase inhibitors
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
mutation
Locally Advanced Malignant Neoplasm
neoplasm metastasis
disease progression
product surveillance, postmarketing
alectinib
Alectinib hydrochloride (substance)
drug information
alectinib
alectinib
carbazoles
piperidines
carbazoles
piperidines
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
Summary Basis of Decision (SBD) for Blexten
Bilastine, 20 mg, tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00282
2016
false
false
false
Canada
French
English
administration, oral
bilastine
Product containing bilastine (medicinal product)
drug information
histamine h1 antagonists
rhinitis, allergic, seasonal
adolescent
adult
urticaria
chronic disease
Chronic spontaneous urticaria
drug approval
canada
bilastine
tablets
benzimidazoles
piperidines

---
https://www.has-sante.fr/portail/jcms/c_2679466/fr/medicaments-de-la-maladie-d-alzheimer-un-interet-medical-insuffisant-pour-justifier-leur-prise-en-charge-par-la-solidarite-nationale
2016
false
false
false
France
French
drug evaluation
alzheimer disease
treatment outcome
evaluation of the transparency committee
donepezil hydrochloride
donepezil
cholinesterase inhibitors
cholinesterase inhibitors
insurance, health, reimbursement
alzheimer disease
memantine
memantine
memantine hydrochloride
receptors, n-methyl-d-aspartate
excitatory amino acid antagonists
excitatory amino acid antagonists
administration, oral
administration, cutaneous
Rivastigmine
rivastigmine
galantamine
Galanthamine Hydrobromide
quality of life
galantamine
indans
piperidines
Donepezil

---
http://www.cochrane.org/fr/CD007654/les-effets-long-terme-des-medicaments-amaigrissants-chez-les-personnes-presentant-une-elevation-de
2016
false
United Kingdom
France
French
meta-analysis
treatment outcome
hypertension
anti-obesity agents
overweight
appetite depressants
lactones
sibutramine
piperidines
pyrazoles
cyclobutanes
french abstract
Rimonabant
Orlistat

---
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54454a-fra.php
2015
false
false
false
Canada
French
English
drug interactions
repaglinide
repaglinide
clopidogrel
diabetes mellitus, type 2
hypoglycemic agents
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
hypoglycemia
pharmacovigilance note
Cytochrome P-450 CYP2C8 Inhibitors
carbamates
piperidines
Contraindications, Drug
Clopidogrel

---
https://www.ema.europa.eu/medicines/human/EPAR/Cotellic
2015
false
false
false
United Kingdom
French
English
summary of product characteristics
package leaflet
cobimetinib
cobimetinib
vemurafenib
melanoma
neoplasm metastasis
administration, oral
MAP kinase kinase 1
antineoplastic agents
antineoplastic agents
adult
continuity of patient care
drug evaluation
syndication feed
drug approval
europe
treatment outcome
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
antineoplastic combined chemotherapy protocols
melanoma
BRAF gene mutation
cobimetinib
Cobimetinib/Vemurafenib Regimen
Tyrosine Kinase Inhibitors
cobimetinib
cobimetinib
azetidines
piperidines
azetidines
piperidines
indoles
sulfonamides
Vemurafenib

---
http://www.has-sante.fr/portail/jcms/c_2030577/fr/levophta-levofree
2015
true
France
French
levocabastine hydrochloride
levocabastine
ophthalmic solutions
conjunctivitis, allergic
histamine H1 antagonists, non-sedating
levocabastine
piperidines
insurance, health, reimbursement
adult
child
treatment outcome
administration, ophthalmic
evaluation of the transparency committee

---
https://www.revmed.ch/RMS/2014/RMS-N-414/Rhumatologie-Une-nouvelle-option-therapeutique-dans-la-prise-en-charge-de-l-inflammation-chronique-en-rhumatologie-les-inhibiteurs-des-Janus-kinases
2014
false
false
false
Switzerland
piperidines
journal article
tofacitinib
protein kinase inhibitors
pyrimidines
pyrroles
tofacitinib
protein kinase inhibitors
piperidines
pyrimidines
pyrroles
arthritis, rheumatoid

---
http://www.has-sante.fr/portail/jcms/c_1774100/fr/vipdomet
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
drug combinations
metformin
hypoglycemic agents
Alogliptin Benzoate
metformin and alogliptin
alogliptin
dipeptidyl-peptidase iv inhibitors
incretins
adult
diabetes mellitus, type 2
treatment outcome
insurance, health, reimbursement
drug therapy, combination
piperidines
uracil
uracil

---
http://www.has-sante.fr/portail/jcms/c_1774095/fr/vipidia
2014
false
false
false
France
French
evaluation of the transparency committee
alogliptin
Alogliptin Benzoate
administration, oral
insurance, health, reimbursement
alogliptin
hypoglycemic agents
incretins
dipeptidyl-peptidase iv inhibitors
drug therapy, combination
diabetes mellitus, type 2
adult
treatment outcome
Product containing alogliptin (medicinal product)
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet (clinical drug)
piperidines
uracil
uracil

---
https://www.ema.europa.eu/medicines/human/EPAR/Novonorm
2012
United Kingdom
English
French
syndication feed
carbamates
piperidines
hypoglycemic agents
carbamates
piperidines
hypoglycemic agents
drug interactions
treatment outcome
drug evaluation
pregnancy
drug approval
drug labeling
tablets
administration, oral
drug therapy, combination
breast feeding
diabetes mellitus, type 2
repaglinide
repaglinide
repaglinide
carbamates
piperidines
summary of product characteristics
drug evaluation
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Prandin
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
carbamates
diabetes mellitus, type 2
piperidines
drug interactions
carbamates
piperidines
hypoglycemic agents
treatment outcome
drug evaluation
drug labeling
drug approval
tablets
administration, oral
drug therapy, combination
pregnancy
breast feeding
repaglinide
repaglinide
repaglinide
carbamates
piperidines
summary of product characteristics
package leaflet
drug evaluation

---
http://www.cochrane.org/fr/CD001924
2010
false
true
false
United Kingdom
France
lubeluzole
piperidines
thiazoles
treatment outcome
review of literature
french abstract
stroke
piperidines
thiazoles

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/levofree_-_ct-8108.pdf
http://www.has-sante.fr/portail/jcms/c_969542/levofree
http://www.has-sante.fr/portail/jcms/c_996404/levofree-levocabastine-collyre-antihistaminique
2010
France
French
levocabastine
ophthalmic solutions
conjunctivitis, allergic
histamine H1 antagonists, non-sedating
levocabastine
piperidines
instillation, drug
insurance, health, reimbursement
adult
child
treatment outcome
levocabastine
piperidines
piperidines
administration, ophthalmic
guidelines for drug use
evaluation of the transparency committee

---
http://www.lecrat.eu/?s=Naratriptan
2009
France
French
pregnancy
piperidines
tryptamines
vasoconstrictor agents
serotonin receptor agonists
naratriptan
naratriptan
piperidines
tryptamines
drug information

---
https://rmlg.uliege.be/article/1699
2008
Belgium
French
piperidines
pyrazoles
receptor, cannabinoid, CB1
journal article
Rimonabant

---
http://www.lecrat.eu/?s=Ebastine
2008
France
French
pregnancy
histamine h1 antagonists
butyrophenones
piperidines
ebastine
ebastine
drug information

---
http://www.meddispar.fr/medicaments/3444950
2008
France
French
piperidines
administration, oral
continuity of patient care
drug monitoring
indans
drug prescriptions
legislation, drug
tablets
donepezil
donepezil hydrochloride
drug information
Donepezil

---
http://www.meddispar.fr/medicaments/3730609
2008
France
French
piperidines
administration, oral
continuity of patient care
drug monitoring
indans
drug prescriptions
legislation, drug
tablets
donepezil
donepezil hydrochloride
drug information
Donepezil

---
https://www.ema.europa.eu/medicines/human/EPAR/Acomplia
2008
United Kingdom
French
English
syndication feed
Contraindications, Procedure
obesity
piperidines
piperidines
pyrazoles
pyrazoles
receptor, cannabinoid, CB1
drug evaluation
treatment outcome
adult
tablets
administration, oral
piperidines
pyrazoles
anti-obesity agents
piperidines
pyrazoles
piperidines
piperidines
pyrazoles
pyrazoles
risk factors
drug interactions
pregnancy
breast feeding
pyrazoles
piperidines
pyrazoles
piperidines
drug evaluation, preclinical
rimonabant
piperidines
pyrazoles
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug
Rimonabant

---
https://www.ema.europa.eu/medicines/human/EPAR/Zimulti
2008
United Kingdom
English
French
syndication feed
drug evaluation
obesity
piperidines
pyrazoles
treatment outcome
piperidines
pyrazoles
anti-obesity agents
adult
pregnancy
breast feeding
tablets
administration, oral
drug evaluation, preclinical
risk factors
drug interactions
piperidines
pyrazoles
piperidines
piperidines
pyrazoles
pyrazoles
piperidines
pyrazoles
piperidines
pyrazoles
receptor, cannabinoid, CB1
rimonabant
piperidines
pyrazoles
drug evaluation
package leaflet
summary of product characteristics
Rimonabant

---
http://www.lecrat.eu/?s=Rimonabant+-+Acomplia%C2%AE
2007
France
French
pregnancy
breast feeding
receptors, cannabinoid
piperidines
pyrazoles
anti-obesity agents
rimonabant
piperidines
pyrazoles
drug information
Rimonabant

---
http://www.has-sante.fr/portail/display.jsp?id=c_594386
http://www.has-sante.fr/portail/display.jsp?id=c_594403
2007
true
France
French
alzheimer disease
indans
piperidines
cholinesterase inhibitors
dopamine agents
galantamine
phenylcarbamates
memantine
excitatory amino acid antagonists
anti-dementia drugs
patient care management
guidelines for drug use

---
https://minerva-ebp.be/fr/article/637
2006
false
false
minerva-ebm.be
Belgium
French
weight loss
obesity
treatment outcome
piperidines
pyrazoles
cardiovascular diseases
risk factors
receptor, cannabinoid, CB1
adult
piperidines
pyrazoles
critical appraisal or critical reading
Rimonabant

---
https://kce.fgov.be/fr/traitement-pharmacologique-et-chirurgical-de-lobesite-prise-en-charge-residentielle-des-enfants
2006
false
Belgium
French
English
pediatric obesity
obesity
obesity
child
belgium
adolescent
Cost-Benefit analysis
liability, legal
bariatric surgery
treatment outcome
anti-obesity agents
lactones
appetite depressants
cyclobutanes
piperidines
pyrazoles
weight loss
bariatric surgery
adult
patient care management
health policy guidelines
health technology assessment

---
https://www.cadth.ca/fr/inhibiteurs-de-la-cholinesterase-pour-la-maladie-dalzheimer-examen-systematique-des-essais-cliniques
2005
true
Canada
French
Therapy cessation
alzheimer disease
cholinesterase inhibitors
Evidence-Based medicine
treatment outcome
canada
aged
disability evaluation
cholinesterase inhibitors
quality of life
alzheimer disease
prevalence
institutionalization
clinical trials as topic
indans
piperidines
galantamine
phenylcarbamates
data collection
anticholinesterases
meta-analysis
evaluation studies
technical report
french abstract
drug evaluation

---
https://www.amub-ulb.be/system/files/rmb/old/192
2005
false
Belgium
French
Ezetimibe
hypolipidemic agents
fatty acids, Omega-3
piperidines
niacin
anticholesteremic agents
pyrazoles
docosahexaenoic acids
eicosapentaenoic acid
Omacor
drug combinations
journal article
Rimonabant

---
Nous contacter.
28/11/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.